APOGEE BIOTECHNOLOGY CORPORATION

HUMMELSTOWN, United States · Founded 2015 · $525K raised

Employees
1–10
Founded
2015
Business Model
B2G
Total Funding
$525K
Last Round
$225K GrantJan 2017
Rounds
2

About

Apogee Biotechnology Corporation develops orally available small molecule inhibitors of sphingosine kinase for the treatment of solid tumors and chronic inflammatory diseases. The company's lead compound ABC294640 (opaganib) has demonstrated efficacy in preclinical models of renal, breast, pancreatic, brain, and colon cancers, as well as inflammatory conditions including arthritis, IBD, and COVID-19.

Summary

APOGEE BIOTECHNOLOGY CORPORATION is a Biotech company based in HUMMELSTOWN, United States, founded in 2015. It has raised $525K in total across 2 rounds, most recently a $225K Grant round in Jan 2017. Investors include National Cancer Institute and National Institute of Allergy and Infectious Diseases.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2017
$225K

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

APOGEE BIOTECHNOLOGY CORPORATION on Indexed.vc
<a href="https://indexed.vc/companies/apogee-biotechnology-corporation"><img src="https://indexed.vc/api/badge/company/apogee-biotechnology-corporation" alt="APOGEE BIOTECHNOLOGY CORPORATION on Indexed.vc" width="260" height="76" /></a>